Výsledky vyhledávání - "Letizia Sidella"

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study)

Autor: Annalisa Mondi, Gabriella d'Ettorre, Rita Murri, Alessandro D'Avino, Manuela Colafigli, Andrea De Luca, Nicoletta Ciccarelli, Serena Fortuna, Letizia Sidella, F. Paoletti, Vincenzo Vullo, Simona Di Giambenedetto, Massimiliano Fabbiani, Roberto Cauda

Publikováno v: Scandinavian Journal of Infectious Diseases. 46:34-45

The Raltegravir Switch for Toxicity or Adverse Events (RASTA) Study is a 2-arm randomized pilot study exploring the safety and efficacy at 48 weeks of a treatment switch to raltegravir associated with tenofovir/emtricitabine or abacavir/lamivudine in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91092bfd6065789890313e0fadfb826
https://doi.org/10.3109/00365548.2013.840920

Zobrazit plný text záznamu

HIV-infected patients show impaired cellular immune response to influenza vaccination compared to healthy subjects

Autor: Alessandro Sgambato, Massimiliano Fabbiani, Rosa Martucci, Michela Sali, Simona Di Giambenedetto, Manuela Colafigli, Roberto Cauda, Maddalena Corbi, Giovanni Delogu, Letizia Sidella

Detailed data on cellular immune response to influenza vaccination in HIV-infected patients are lacking. We analyzed cellular (IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, IFN-γ, TNF-α, GM-CSF) and humoral (IgG and IgM) immune response in 81 HIV-infected

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0631526dd01ffba365e3df9b3e07d72d
http://hdl.handle.net/10807/54128

Zobrazit plný text záznamu

Safety and feasibility of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors + atazanavir/ritonavir with virological suppression (Atazanavir and Lamivudine for treatment Simplification, AtLaS pilot study)

Autor: Alessandro D'Avino, Annalisa Mondi, Antonella Cingolani, Manuela Colafigli, Enrica Tamburrini, Simona Di Giambenedetto, Andrea De Luca, Roberto Cauda, Pierluigi Navarra, Massimiliano Fabbiani, Salvatore Farina, Nicoletta Ciccarelli, Letizia Sidella, Rita Murri

OBJECTIVES To explore 48 week safety and efficacy of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression on a stable atazanavir/ritonavir-based standard triple regimen. METHODS This was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e41819187f0a290837fea7cf8ab9cb
http://hdl.handle.net/10807/39882

Zobrazit plný text záznamu

Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy

Autor: Francesco Saladini, C. Caudai, Andrea De Luca, Simona Di Giambenedetto, Francesco Pippi, Genny Meini, Barbara Rossetti, Ilaria Vicenti, Maurizio Zazzi, P. Almi, Andrea Rosi, Letizia Sidella

Publikováno v: Journal of Antimicrobial Chemotherapy; Vol 67

To assess the prevalence of hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) resistance mutations in HCV genotype 1-infected PI-naive individuals in Italy.One hundred and twelve patients infected with HCV genotype 1a or 1b (based on Versant HCV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a474b1b0b7099ad6804e43b87740575
https://pubmed.ncbi.nlm.nih.gov/22258932

Zobrazit plný text záznamu

Lipid-lowering effect of tenofovir in HIV-infected patients

Autor: Laura Bracciale, Maria Doino, Andrea De Luca, Valentina Di Cristo, Massimiliano Fabbiani, Salvatore Farina, Simona Di Giambenedetto, Roberto Cauda, Letizia Sidella

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d31c506ae0b605407248ae0716a3ec5
http://hdl.handle.net/11365/1011683

Zobrazit plný text záznamu

Barasertib: a novel approach for the treatment of metastatic melanoma

Autor: Rosa Maria Iacobazzi, Immacolata Maida, Letizia Porcelli, Stefani Tommasi, Anna Ferretta, Anna Elisa Quatrale, Tiziana Cocco, Sabino Strippoli, Angelo Paradiso, Michele Guida, Stefania Giuda, Amalia Azzariti, Letizia Sidella, Gabriella Guida

Publikováno v: Journal of Translational Medicine

Background Metastatic melanoma represents the most deadly form of skin cancer. The poor response to chemotherapy and the brief response to the anti-BRAF vemurafenib in selected population of patients, make the identification of new therapeutic approa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8fa2eef55118ac9f4ee9871a6dc31b4

Zobrazit plný text záznamu

Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy

Autor: Anna Elisa Quatrale, Immacolata Maida, Tiziana Cocco, Gabriella Guida, Michele Guida, Sabino Strippoli, Diana A Stolfa, Amalia Azzariti, Stefania Tommasi, Stefania Guida, Letizia Sidella, Rosa Maria Iacobazzi, Letizia Porcelli, Anna Ferretta

Publikováno v: Journal of Translational Medicine

Background The poor response to chemotherapy and the brief response to vemurafenib in metastatic melanoma patients, make the identification of new therapeutic approaches an urgent need. Interestingly the increased expression and activity of the Auror

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b531798f60a6692b43cf40bad5d9710

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání